IL141165A0 - New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same - Google Patents
New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the sameInfo
- Publication number
- IL141165A0 IL141165A0 IL14116599A IL14116599A IL141165A0 IL 141165 A0 IL141165 A0 IL 141165A0 IL 14116599 A IL14116599 A IL 14116599A IL 14116599 A IL14116599 A IL 14116599A IL 141165 A0 IL141165 A0 IL 141165A0
- Authority
- IL
- Israel
- Prior art keywords
- inhibition
- preparing
- pharmaceutical compositions
- same
- acid secretion
- Prior art date
Links
- 230000009858 acid secretion Effects 0.000 title 1
- 125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9802793A SE9802793D0 (sv) | 1998-08-21 | 1998-08-21 | New compounds |
| PCT/SE1999/001401 WO2000010999A2 (en) | 1998-08-21 | 1999-08-18 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL141165A0 true IL141165A0 (en) | 2002-11-10 |
Family
ID=20412306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14116599A IL141165A0 (en) | 1998-08-21 | 1999-08-18 | New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6613775B1 (xx) |
| EP (1) | EP1105390B1 (xx) |
| JP (1) | JP2002523414A (xx) |
| KR (1) | KR20010072797A (xx) |
| CN (1) | CN1161355C (xx) |
| AR (1) | AR020225A1 (xx) |
| AT (1) | ATE242242T1 (xx) |
| AU (1) | AU770511B2 (xx) |
| BR (1) | BR9913102A (xx) |
| CA (1) | CA2339372A1 (xx) |
| DE (1) | DE69908608T2 (xx) |
| DK (1) | DK1105390T3 (xx) |
| ES (1) | ES2201769T3 (xx) |
| IL (1) | IL141165A0 (xx) |
| MY (1) | MY121387A (xx) |
| NO (1) | NO20010861L (xx) |
| NZ (1) | NZ509744A (xx) |
| PT (1) | PT1105390E (xx) |
| SE (1) | SE9802793D0 (xx) |
| WO (1) | WO2000010999A2 (xx) |
| ZA (1) | ZA200100911B (xx) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| SE9802794D0 (sv) * | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| MXPA04008070A (es) | 2003-03-10 | 2004-11-26 | Altana Pharma Ag | Novedoso proceso para la preparacion de roflumilasto. |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20060194782A1 (en) * | 2003-09-18 | 2006-08-31 | Altana Pharma Ag | Pharmacologically active imidazo[4,5-c] pyridines |
| AU2004285394B2 (en) | 2003-11-03 | 2009-01-08 | Astrazeneca Ab | Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| CA2575345A1 (en) * | 2004-08-02 | 2006-02-09 | Altana Pharma Ag | 5-substituted 1h-pyrrolo[3,2-b]pyridines |
| KR101068355B1 (ko) * | 2005-03-09 | 2011-09-28 | 주식회사유한양행 | 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법 |
| EP1861074B1 (en) | 2005-03-16 | 2013-04-24 | Takeda GmbH | Taste masked dosage form containing roflumilast |
| PE20061110A1 (es) * | 2005-03-24 | 2006-10-20 | Glaxo Group Ltd | Derivados de imidazopiridina como antagonistas de la bomba de acido (apa) |
| EP2451796B1 (en) | 2009-07-08 | 2013-04-17 | Dermira (Canada), Inc. | Tofa analogs useful in treating dermatological disorders or conditions |
| RU2586276C2 (ru) | 2009-07-09 | 2016-06-10 | Раквалиа Фарма Инк. | Антагонист кислотного насоса для лечения заболеваний, связанных с патологическим нарушением моторики желудочно-кишечного тракта |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA81219B (en) * | 1980-01-23 | 1982-01-27 | Schering Corp | Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them |
| EP0068378B1 (en) | 1981-06-26 | 1986-03-05 | Schering Corporation | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| US4725601A (en) | 1985-06-04 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers |
-
1998
- 1998-08-21 SE SE9802793A patent/SE9802793D0/xx unknown
-
1999
- 1999-08-18 US US09/403,510 patent/US6613775B1/en not_active Expired - Lifetime
- 1999-08-18 BR BR9913102-1A patent/BR9913102A/pt not_active IP Right Cessation
- 1999-08-18 NZ NZ509744A patent/NZ509744A/en unknown
- 1999-08-18 DE DE69908608T patent/DE69908608T2/de not_active Expired - Fee Related
- 1999-08-18 WO PCT/SE1999/001401 patent/WO2000010999A2/en not_active Ceased
- 1999-08-18 CA CA002339372A patent/CA2339372A1/en not_active Abandoned
- 1999-08-18 JP JP2000566272A patent/JP2002523414A/ja active Pending
- 1999-08-18 CN CNB998121770A patent/CN1161355C/zh not_active Expired - Fee Related
- 1999-08-18 PT PT99944965T patent/PT1105390E/pt unknown
- 1999-08-18 KR KR1020017002151A patent/KR20010072797A/ko not_active Ceased
- 1999-08-18 DK DK99944965T patent/DK1105390T3/da active
- 1999-08-18 EP EP99944965A patent/EP1105390B1/en not_active Expired - Lifetime
- 1999-08-18 ES ES99944965T patent/ES2201769T3/es not_active Expired - Lifetime
- 1999-08-18 IL IL14116599A patent/IL141165A0/xx unknown
- 1999-08-18 AT AT99944965T patent/ATE242242T1/de not_active IP Right Cessation
- 1999-08-18 AU AU57678/99A patent/AU770511B2/en not_active Ceased
- 1999-08-19 MY MYPI99003559A patent/MY121387A/en unknown
- 1999-08-19 AR ARP990104162A patent/AR020225A1/es not_active Application Discontinuation
-
2001
- 2001-02-01 ZA ZA200100911A patent/ZA200100911B/en unknown
- 2001-02-20 NO NO20010861A patent/NO20010861L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200100911B (en) | 2002-05-02 |
| NZ509744A (en) | 2003-05-30 |
| NO20010861D0 (no) | 2001-02-20 |
| WO2000010999A3 (en) | 2000-06-02 |
| AU5767899A (en) | 2000-03-14 |
| NO20010861L (no) | 2001-04-10 |
| PT1105390E (pt) | 2003-10-31 |
| KR20010072797A (ko) | 2001-07-31 |
| CA2339372A1 (en) | 2000-03-02 |
| ATE242242T1 (de) | 2003-06-15 |
| WO2000010999A2 (en) | 2000-03-02 |
| MY121387A (en) | 2006-01-28 |
| BR9913102A (pt) | 2001-05-08 |
| ES2201769T3 (es) | 2004-03-16 |
| DE69908608T2 (de) | 2004-04-29 |
| DE69908608D1 (de) | 2003-07-10 |
| EP1105390B1 (en) | 2003-06-04 |
| AR020225A1 (es) | 2002-05-02 |
| AU770511B2 (en) | 2004-02-26 |
| HK1036274A1 (en) | 2001-12-28 |
| DK1105390T3 (da) | 2003-09-22 |
| US6613775B1 (en) | 2003-09-02 |
| EP1105390A2 (en) | 2001-06-13 |
| CN1161355C (zh) | 2004-08-11 |
| SE9802793D0 (sv) | 1998-08-21 |
| JP2002523414A (ja) | 2002-07-30 |
| CN1323308A (zh) | 2001-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL136145A0 (en) | Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof | |
| HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
| HUP0204226A3 (en) | Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds | |
| HUP0103376A3 (en) | New 3-aryl-2-hydroxypropionic acid derivative, pharmaceutical compositions containing it, process for their preparation and their use | |
| HUP0004120A3 (en) | Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy | |
| HUP0202100A3 (en) | Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same | |
| HUP0203183A3 (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0102425A3 (en) | Imidazo pyridine derivatives which inhibit gastric acid secretion, process for producing them and pharmaceutical compositions containing them | |
| HUP0104964A3 (en) | Quinazoline derivatives as angiogenesis inhibitors, process for their preparation and medicaments containing the compounds | |
| HUP0203122A3 (en) | Fab i inhibitors, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203542A3 (en) | 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same | |
| HUP0203136A3 (en) | Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0200881A2 (en) | Renin inhibitors, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
| HUP0300592A3 (en) | Process for the preparation of 2-halobenzoic acid derivatives | |
| IL141165A0 (en) | New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same | |
| HUP0301075A3 (en) | Diphenyl ether derivatives, their use for preparation of pharmaceutical compositions and process for preparation the compounds | |
| IL146104A0 (en) | Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same | |
| HUP0100277A3 (en) | 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as metalloproteinase inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203471A3 (en) | Antithrombotic compound, process for their preparation, pharmaceutical compositions containing them and their use | |
| EG22344A (en) | Process for preparing of novel pharmaceutical composition | |
| PL352280A1 (en) | Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives | |
| IL131644A0 (en) | Process for the preparation of nicotinic acid | |
| HUP9903747A3 (en) | New process for the preparation of mometasone furoate | |
| HUP0103788A3 (en) | Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives | |
| HUP0202988A3 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them |